Medical device innovation: Prospective solutions for an ecosystem in crisis: Adding a professional society perspective

JACC: Cardiovascular Interventions

Volumn 5, Issue 7, 2012, Pages 790-796

  Krucoff, Mitchell W ^a   Brindis, Ralph G ^b   Hodgson, Patricia K ^a   MacK, Michael J ^c   Holmes, David R ^d  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Heart Hospital Baylor   (United States)

^d MAYO CLINIC   (United States)

Author keywords

innovation; medical device; safety; society

Indexed keywords

CARDIOVASCULAR EQUIPMENT; CLINICAL PRACTICE; CLINICAL RESEARCH; DEVICE APPROVAL; DEVICE SAFETY; ECONOMIC EVALUATION; ELECTRONIC MEDICAL RECORD; FOOD AND DRUG ADMINISTRATION; GOVERNMENT; HEALTH CARE ACCESS; HEALTH CARE QUALITY; HUMAN; MEDICAL DEVICE; MEDICAL TECHNOLOGY; ORGANIZATION; PRIORITY JOURNAL; PRODUCT DEVELOPMENT; PUBLIC OPINION; QUALITY CONTROL; REIMBURSEMENT; REVIEW; RISK ASSESSMENT; STATISTICAL ANALYSIS; UNITED STATES;

EID: 84864060430     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2012.03.023     Document Type: Review

References (30)

1. U.S. Food and Drug Administration FDA's Critical Path Initiative http://www.fda.gov/ScienceResearch/SpecialTopics/CriticalPathInitiative/ ucm076689.htm January 2011 Accessed August 21, 2011
2. Global Harmonization Task Force Welcome to the Global Harmonization Task Force Website http://www.ghtf.org/ Accessed August 21, 2011
3. U.S. Food and Drug Administration Medical Device Innovation Initiative White Paper: CDRH Innovation Initiative http://www.fda.gov/AboutFDA/ CentersOffices/OfficeofMedicalProductsandTobacco/CDRH/CDRHInnovation/ucm242067. htm February 2011 Accessed August 21, 2011
4. S.S. Dhruva, L.A. Bero, R.F. Redberg Strength of study evidence examined by the FDA in premarket approval of cardiovascular devices JAMA 302 2009 2679 2685
5. G.D. Curfman, R.F. Redberg Medical devices - balancing regulation and innovation N Engl J Med 365 2011 975 977
6. Institute of Medicine Medical Devices and the Public's Health: The FDA 510(k) Clearance Process at 35 Years Consensus Report http://www.iom.edu/ Reports/2011/Medical-Devices-and-the-Publics-Health-The-FDA-510k-Clearance- Process-at-35-Years.aspx July 29, 2011 Accessed August 14, 2011
7. M.W. Krucoff, A. Boam, D.G. Schultz Drug-eluting stents "deliver heartburn": how do we spell relief going forward? Circulation 115 2007 2990 2994 (Pubitemid 46912105)
8. International Organization for Standardization ISO 14971:2007: Medical Devices - Application of Risk Management to Medical Devices http://www.iso.org/ iso/iso-catalogue/catalogue-tc/catalogue-detail.htm?csnumber=44908 November 2, 2010 Accessed August 15, 2011
9. Study Group 5 Post: Global Harmonization Task Force - Market Clinical Follow Up Studies http://www.ghtf.org/sg5/sg5-final.html Accessed August 15, 2011
10. International Organization for Standardization ISO 14155-1: 2003: Clinical Investigation of Medical Devices for Human Subjects - Part 1 General requirements http://www.iso.org/iso/iso-catalogue/catalogue-tc/catalogue-detail? csnumber=45557.htm Accessed August 15, 2011
11. Global Harmonization Task ForceStudy Group 5 Clinical Investigations Pdf http://www.ghtf.org/sg5/sg5-final.html February 12, 2010 Accessed August 15, 2011
12. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Devices and Radiological Health, Division of Biostatistics, Office of Surveillance and Biometrics Guidance for Industry and FDA Staff: Guidance for the Use of Bayesian Statistics in Medical Device Clinical Trials Pdf http://www.fda.gov/downloads/MedicalDevices/ DeviceRegulationandGuidance/GuidanceDocuments/ucm071121.pdf February 5, 2010 Accessed August 18, 2011
13. R.P. Merkow, C.Y. Ko Evidence-based medicine in surgery: the importance of both experimental and observational study designs JAMA 306 2011 436 437
14. C. Berry, D.R. Murdoch, J.J. McMurray Economics of chronic heart failure Eur J Heart Fail 3 2001 283 291 (Pubitemid 32895835)
15. D.L. DeMets, R.M. Califf A historical perspective on clinical trials innovation and leadership: where have the academics gone? JAMA 305 2011 713 714
16. A.G. Fraser, J.C. Daubert, F. Van de Werf Clinical evaluation of cardiovascular devices: principles, problems, and proposals for European regulatory reform Report of a policy conference of the European Society of Cardiology Eur Heart J 32 2011 1673 1686
17. Cardiac Safety Research Consortium Home page http://www.cardiac-safety. org Accessed August 15, 2011
18. S.M. Al-Khatib, H. Calkins, B.C. Eloff Developing the Safety of Atrial Fibrillation Ablation Registry Initiative (SAFARI) as a collaborative pan-stakeholder critical path registry model: a Cardiac Safety Research Consortium "Incubator" Think Tank Am Heart J 160 2010 619 626
19. P. Kligfield, C.L. Green, J. Mortara The Cardiac Safety Research Consortium electrocardiogram warehouse: thorough QT database specifications and principles of use for algorithm development and testing Am Heart J 160 2010 1023 1028
20. Department of Health and Human Services. Centers for Medicare and Medicaid Services. Food and Drug Administration. [Docket No. FDA-2010-N-0308] Parallel review of medical products. Federal Register 2010;75:57045. Available at: http://edocket.access.gpo.gov/2010/pdf/2010-23252.pdf. Accessed August 11, 2011
21. National Coverage Analysis (NCA) Tracking Sheet for Transcatheter Aortic Valve Replacement (TAVR) (CAG-00430N). Available at: https://www.cms.gov/ medicare-coverage-database/details/nca-tracking-sheet.aspx?NCAId=257&ver= 1&NcaName=Transcathereter+Aortic+Valve+Replacement+%28TAVR%29&bc= ACAAAAAAIAAA. Accessed June 2012.
22. D.J. Kereiakes, R.E. Kuntz, L. Mauri, M.W. Krucoff Surrogates, substudies, and real clinical end points in trials of drug-eluting stents J Am Coll Cardiol 45 2005 1206 1212 (Pubitemid 40523138)
23. T.Y. Wang, V. Hasselblad, J.L. Peterson The Cobalt chromium STent with Antiproliferative for Restenosis II (COSTAR II) trial study design: advancing the active-control evaluation of second-generation drug-eluting stents Am Heart J 153 2007 743 748 (Pubitemid 46602145)
24. U.S. Food and Drug Administration FDA's Sentinel Initiative http://www.fda.gov/Safety/FDAsSentinelInitiative/ucm2007250.htm Accessed August 11, 2011
25. J.S. Rumsfeld, E.D. Peterson Achieving meaningful device surveillance: from reaction to proaction JAMA 304 2010 2065 2066
26. Department of Veterans Affairs. Veterans Health Administration Cardiac Assessment Reporting and Tracking System for Cardiac Catheterization Laboratories (CART-CL) VHA Directive 2005-062 http://www.va.gov/vhapublications/ publications.cfm?pub=1 December 13, 2005 Accessed August 15, 2011
27. F.S. Resnic, T.P. Gross, D. Marinac-Dabic Automated surveillance to detect postprocedure safety signals of approved cardiovascular devices JAMA 304 2010 2019 2027
28. U.S. National Institutes of Health Study of Access Site for Enhancement of PCI for Women (SAFE-PCI for Women) [database listing] http://www. clinicaltrials.gov/ct2/show/NCT01406236?term-SAFE-PCI-for-Women&rank-1 June 20, 2011 Accessed August 22, 2011
29. M.W. Krucoff, R. Mehran, G.A. van Es, A.B. Boam, D.E. Cutlip The Academic Research Consortium governance charter J Am Coll Cardiol Intv 4 2011 596 597
30. A.G. Fraser, M.W. Krucoff, R.G. Brindis, M. Komajda, S.C. Smith Jr Commentary: international collaboration needed on device clinical standards BMJ 342 2011 d2952